ClinicalTrials.Veeva

Menu

Pain Biomarker Study (PBS)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Invitation-only
Phase 1

Conditions

Short-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing
Paroxysmal Hemicrania
Trigeminal Autonomic Cephalgia
Migraine
SUNCT
Hemicrania Continua
Cluster Headache

Treatments

Drug: Intranasal capsaicin
Other: Cold Water Irrigation
Drug: Low Flow Oxygen
Other: Medical Air
Drug: High Flow Oxygen
Drug: Oral capsaicin
Drug: Topical capsaicin

Study type

Interventional

Funder types

Other

Identifiers

NCT03511846
HSC-MS-17-0763

Details and patient eligibility

About

This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases.

There are 3 main parts:

  1. Use of capsaicin (active ingredient in hot chili peppers) to trigger release of calcitonin gene related peptide - the hypothesis is that this will be different in headache subjects compared to controls (and if so might be used to predict how these patients will respond to certain medications that modulate calcitonin gene-related peptide). Subjects will be given capsaicin as a cream applied to the forehead or the inner nostril, or a hot sauce that is ingested.
  2. Use of capsaicin to trigger eye watering - the hypothesis is that oxygen gas will slow down the amount of eye watering. Cluster headache patients respond very powerfully to oxygen gas but to very little else. The mechanism for oxygen is unknown but in rodents there is data that it works on the parasympathetic / lacrimal gland system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment.
  3. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders.

Enrollment

371 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of one of the following: a. Diagnosis of a primary headache disorder according to the International Headache Classification, including migraine with aura, migraine without aura, chronic migraine, tension headache, cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), and hemicrania continua; b. Diagnosed by a pain medicine physician with lumbar radiculopathy (possibly including neuropathic features, nerve impingement on MRI, or electromyography (EMG) report suggestive of lumbar radiculopathy); or c. Healthy control subject with no history of debilitating headaches or debilitating back pain / radiculopathy pain, and no headaches or back pain within the previous 3 months.
  • Able to provide HIPAA authorization to share prior medical records/imaging
  • Age 18 and older

Exclusion criteria

  • The following items exclude the subject from all portions of the study: a. Known history of cardiovascular or neurovascular diseases. These diseases may include carotid stenosis of >50%, vertebral stenosis, peripheral vascular disease, angina or myocardial infarction, stroke, or vascular malformations; b. History of brain tumors or epilepsy; c. Active pregnancy or lactation; d. Daily cigarette, tobacco or nicotine use; e. Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of headache or spine pain; f. Active drug / alcohol use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements; or g. Inability or unwillingness of subject to give informed consent (e.g., ward of the state)
  • The following items exclude the subject only from the capsaicin portion of the study: a. Known allergy to capsaicin or hot peppers
  • The following items exclude the subject only from the oxygen portion of the study: a. Pulmonary or other non-headache diseases that require the use of supplemental oxygen
  • The following items exclude the subject only from the cold water irrigation (ice water) portion of the study: a. Trauma, fractures, or congenital abnormalities of the soft palate

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

371 participants in 16 patient groups

Oral capsaicin
Experimental group
Treatment:
Drug: Oral capsaicin
Oral capsaicin and Medical Air
Sham Comparator group
Treatment:
Drug: Oral capsaicin
Other: Medical Air
Oral Capsaicin and Low Flow Oxygen
Experimental group
Treatment:
Drug: Oral capsaicin
Drug: Low Flow Oxygen
Oral capsaicin and High Flow Oxygen
Experimental group
Treatment:
Drug: Oral capsaicin
Drug: High Flow Oxygen
Topical capsaicin
Experimental group
Treatment:
Drug: Topical capsaicin
Topical capsaicin and Medical Air
Sham Comparator group
Treatment:
Drug: Topical capsaicin
Other: Medical Air
Topical capsaicin and Low Flow Oxygen
Experimental group
Treatment:
Drug: Topical capsaicin
Drug: Low Flow Oxygen
Topical capsaicin and High Flow Oxygen
Experimental group
Treatment:
Drug: Topical capsaicin
Drug: High Flow Oxygen
Intranasal capsaicin
Experimental group
Treatment:
Drug: Intranasal capsaicin
Intranasal capsaicin and Medical Air
Sham Comparator group
Treatment:
Other: Medical Air
Drug: Intranasal capsaicin
Intranasal capsaicin and Low Flow Oxygen
Experimental group
Treatment:
Drug: Low Flow Oxygen
Drug: Intranasal capsaicin
Intranasal capsaicin and High Flow Oxygen
Experimental group
Treatment:
Drug: High Flow Oxygen
Drug: Intranasal capsaicin
Cold water irrigation
Experimental group
Treatment:
Other: Cold Water Irrigation
Cold water irrigation and Medical Air
Sham Comparator group
Treatment:
Other: Medical Air
Other: Cold Water Irrigation
Cold water irrigation and Low Flow Oxygen
Experimental group
Treatment:
Drug: Low Flow Oxygen
Other: Cold Water Irrigation
Cold water irrigation and High Flow Oxygen
Experimental group
Treatment:
Drug: High Flow Oxygen
Other: Cold Water Irrigation

Trial contacts and locations

1

Loading...

Central trial contact

Mark Burish, MD PhD; Rebecca Martinez, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems